Insider Transactions in Q2 2021 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2021
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-2.47%
|
$53,873
$17.8 P/Share
|
|
May 20
2021
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
3,410
-1.86%
|
$57,970
$17.8 P/Share
|
|
May 20
2021
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
942
-0.51%
|
$16,014
$17.8 P/Share
|
|
May 20
2021
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,779
-0.86%
|
$64,243
$17.8 P/Share
|
|
May 20
2021
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,310
-1.17%
|
$73,270
$17.8 P/Share
|
|
May 20
2021
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,194
-2.07%
|
$88,298
$17.8 P/Share
|
|
May 20
2021
|
Bradford J Shafer EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,310
-1.5%
|
$73,270
$17.8 P/Share
|
|
May 20
2021
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,404
-0.85%
|
$193,868
$17.8 P/Share
|
|
May 20
2021
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Payment of exercise price or tax liability
|
Direct |
4,310
-1.25%
|
$73,270
$17.8 P/Share
|
|
Apr 27
2021
|
Alsup Laurie Smaldone |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+22.02%
|
-
|
|
Apr 27
2021
|
Eran Broshy |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+16.15%
|
-
|
|
Apr 27
2021
|
Robert V Gunderson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+12.61%
|
-
|
|
Apr 27
2021
|
Burton G Malkiel |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+10.75%
|
-
|
|
Apr 27
2021
|
Dean J Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+16.15%
|
-
|
|
Apr 27
2021
|
Susan Molineaux Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+50.0%
|
-
|
|
Apr 27
2021
|
Donal O'Connor |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+18.25%
|
-
|
|
Apr 27
2021
|
George M Whitesides Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+50.0%
|
-
|
|
Apr 27
2021
|
William D Young |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+12.6%
|
-
|
|
Apr 27
2021
|
Deepika Pakianathan |
BUY
Grant, award, or other acquisition
|
Direct |
9,828
+35.45%
|
-
|